Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / NBY - NovaBay Pharma gains 10% on launch of new oral supplement to comfort dry eyes


NBY - NovaBay Pharma gains 10% on launch of new oral supplement to comfort dry eyes

2023-03-07 07:31:59 ET

  • NovaBay Pharmaceuticals ( NYSE: NBY ) jumps 10% premarket after announcing the launch of OTC Avenova Eye Health Support oral supplement featuring a combination of MaquiBright, a nutrient-rich, antioxidant-dense extract of the superfruit maqui berry, and high quality, natural triglyceride omega-3 oils to comfort dry eyes and support overall eye health.
  • Avenova Eye Health Support is sold as 60 easy-to-swallow softgel capsules and is available at Amazon.com and Avenova.com for $41.95, and through optometrist offices.
  • Participants in a four-week, placebo-controlled study on the effects of MaquiBright extract showed an 89% increase in tear production and reported a 57% improvement in dry eye discomfort with Avenova Eye Health Support. Study results were published in the peer-reviewed Journal of Traditional and Complementary Medicine.
  • With the strategic addition of an oral supplement, the Avenova brand now offers a product for each step of the standard dry-eye treatment regimen.

For further details see:

NovaBay Pharma gains 10% on launch of new oral supplement to comfort dry eyes
Stock Information

Company Name: NovaBay Pharmaceuticals Inc.
Stock Symbol: NBY
Market: NYSE
Website: novabay.com

Menu

NBY NBY Quote NBY Short NBY News NBY Articles NBY Message Board
Get NBY Alerts

News, Short Squeeze, Breakout and More Instantly...